...
首页> 外文期刊>Marine Drugs >Anti-Obese Effect of Glucosamine and Chitosan Oligosaccharide in High-Fat Diet-Induced Obese Rats
【24h】

Anti-Obese Effect of Glucosamine and Chitosan Oligosaccharide in High-Fat Diet-Induced Obese Rats

机译:葡萄糖胺和壳聚糖寡糖对高脂饮食诱导的肥胖大鼠的抗肥胖作用

获取原文

摘要

Objective: This study is to evaluate the anti-obese effects of glucosamine (GLC) and chitosan oligosaccharide (COS) on high-fat diet-induced obese rats. Methods: The rats were randomly divided into twelve groups: a normal diet group (NF), a high-fat diet group (HF), Orlistat group, GLC high-, middle-, and low-dose groups (GLC-H, GLC-M, GLC-L), COS1 (COS, number-average molecular weight ≤1000) high-, middle-, and low-dose groups (COS1-H, COS1-M, COS1-L), and COS2 (COS, number-average molecular weight ≤3000) high-, middle-, and low-dose groups (COS2-H, COS2-M, COS2-L). All groups received oral treatment by gavage once daily for a period of six weeks. Results: Rats fed with COS1 gained the least weight among all the groups (P 0.01), and these rats lost more weight than those treated with Orlistat. In addition to the COS2-H and Orlistat groups, the serum total cholesterol (CHO) and low-density lipoprotein cholesterol (LDL-C) levels were significantly reduced in all treatment groups compared to the HF group (P 0.01). The various doses of GLC, COS1 and COS2 reduced the expression levels of PPARγ and LXRα mRNA in the white adipose tissue. Conclusions: The results above demonstrated that GLC, COS1, and COS2 improved dyslipidemia and prevented body weight gains by inhibiting the adipocyte differentiation in obese rats induced by a high-fat diet. Thus, these agents may potentially be used to treat obesity.
机译:目的:本研究旨在评估氨基葡萄糖(GLC)和壳聚糖寡糖(COS)对高脂饮食诱导的肥胖大鼠的抗肥胖作用。方法:将大鼠随机分为十二组:正常饮食组(NF),高脂饮食组(HF),奥利司他组,GLC高,中,低剂量组(GLC-H,GLC) -M,GLC-L),COS1(COS,数均分子量≤1000)高,中和低剂量组(COS1-H,COS1-M,COS1-L)和COS2(COS,数均分子量≤3000)的高,中,低剂量组(COS2-H,COS2-M,COS2-L)。所有组每天接受一次管饲口服治疗,持续六周。结果:饲喂COS1的大鼠在所有组中的体重最小(P <0.01),并且这些大鼠的体重减轻比用Orlistat治疗的大鼠更多。除了COS2-H和Orlistat组,与HF组相比,所有治疗组的血清总胆固醇(CHO)和低密度脂蛋白胆固醇(LDL-C)水平均显着降低(P <0.01)。不同剂量的GLC,COS1和COS2降低了白色脂肪组织中PPARγ和LXRαmRNA的表达水平。结论:以上结果表明,GLC,COS1和COS2可通过抑制高脂饮食诱导的肥胖大鼠的脂肪细胞分化来改善血脂异常并防止体重增加。因此,这些药剂可潜在地用于治疗肥胖症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号